3,853
Views
54
CrossRef citations to date
0
Altmetric
Brief Report

Structure reveals function of the dual variable domain immunoglobulin (DVD-Ig™) molecule

, , , , , & show all
Pages 358-363 | Received 10 Jan 2013, Accepted 12 Feb 2013, Published online: 02 Apr 2013

References

  • Wu C, Ying H, Grinnell C, Bryant S, Miller R, Clabbers A, et al. Simultaneous targeting of multiple disease mediators by a dual-variable-domain immunoglobulin. Nat Biotechnol 2007; 25:1290 - 7; http://dx.doi.org/10.1038/nbt1345; PMID: 17934452
  • Kou G, Shi J, Chen L, Zhang D, Hou S, Zhao L, et al. A bispecific antibody effectively inhibits tumor growth and metastasis by simultaneous blocking vascular endothelial growth factor A and osteopontin. Cancer Lett 2010; 299:130 - 6; http://dx.doi.org/10.1016/j.canlet.2010.08.011; PMID: 20826049
  • Digiammarino EL, Harlan JE, Walter KA, Ladror US, Edalji RP, Hutchins CW, et al. Ligand association rates to the inner-variable-domain of a dual-variable-domain immunoglobulin are significantly impacted by linker design. MAbs 2011; 3:487 - 94; http://dx.doi.org/10.4161/mabs.3.5.16326; PMID: 21814039
  • Wu C, Ying H, Bose S, Miller R, Medina L, Santora L, et al. Molecular construction and optimization of anti-human IL-1alpha/beta dual variable domain immunoglobulin (DVD-Ig) molecules. MAbs 2009; 1:339 - 47; http://dx.doi.org/10.4161/mabs.1.4.8755; PMID: 20068402
  • Winn MD. An overview of the CCP4 project in protein crystallography: an example of a collaborative project. J Synchrotron Radiat 2003; 10:23 - 5; http://dx.doi.org/10.1107/S0909049502017235; PMID: 12511787
  • Lawrence MC, Colman PM. Shape complementarity at protein/protein interfaces. J Mol Biol 1993; 234:946 - 50; http://dx.doi.org/10.1006/jmbi.1993.1648; PMID: 8263940
  • Argiriadi MA, Xiang T, Wu C, Ghayur T, Borhani DW. Unusual water-mediated antigenic recognition of the proinflammatory cytokine interleukin-18. J Biol Chem 2009; 284:24478 - 89; http://dx.doi.org/10.1074/jbc.M109.023887; PMID: 19553661
  • Heiss MM, Murawa P, Koralewski P, Kutarska E, Kolesnik OO, Ivanchenko VV, et al. The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial. Int J Cancer 2010; 127:2209 - 21; http://dx.doi.org/10.1002/ijc.25423; PMID: 20473913
  • Topp MS, Kufer P, Gökbuget N, Goebeler M, Klinger M, Neumann S, et al. Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival. J Clin Oncol 2011; 29:2493 - 8; http://dx.doi.org/10.1200/JCO.2010.32.7270; PMID: 21576633
  • Yu YJ, Zhang Y, Kenrick M, Hoyte K, Luk W, Lu Y, et al. Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target. Sci Transl Med 2011; 3:84ra44; http://dx.doi.org/10.1126/scitranslmed.3002230; PMID: 21613623
  • Metz S, Haas AK, Daub K, Croasdale R, Stracke J, Lau W, et al. Bispecific digoxigenin-binding antibodies for targeted payload delivery. Proc Natl Acad Sci U S A 2011; 108:8194 - 9; http://dx.doi.org/10.1073/pnas.1018565108; PMID: 21536919
  • Zhao TC, Tseng A, Yano N, Tseng Y, Davol PA, Lee RJ, et al. Targeting human CD34+ hematopoietic stem cells with anti-CD45 x anti-myosin light-chain bispecific antibody preserves cardiac function in myocardial infarction. J Appl Physiol 2008; 104:1793 - 800; http://dx.doi.org/10.1152/japplphysiol.01109.2007; PMID: 18292296
  • Otwinowski Z, Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 1997; 276:307 - 26; http://dx.doi.org/10.1016/S0076-6879(97)76066-X
  • McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ. Phaser crystallographic software. J Appl Crystallogr 2007; 40:658 - 74; http://dx.doi.org/10.1107/S0021889807021206; PMID: 19461840
  • Vagin A, Teplyakov A. An approach to multi-copy search in molecular replacement. Acta Crystallogr D Biol Crystallogr 2000; 56:1622 - 4; http://dx.doi.org/10.1107/S0907444900013780; PMID: 11092928
  • Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr 1994; 50:760 - 3; http://dx.doi.org/10.1107/S0907444994003112; PMID: 15299374
  • Murshudov GN, Vagin AA, Dodson EJ. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 1997; 53:240 - 55; http://dx.doi.org/10.1107/S0907444996012255; PMID: 15299926
  • Blanc E, Roversi P, Vonrhein C, Flensburg C, Lea SM, Bricogne G. Refinement of severely incomplete structures with maximum likelihood in BUSTER-TNT. Acta Crystallogr D Biol Crystallogr 2004; 60:2210 - 21; http://dx.doi.org/10.1107/S0907444904016427; PMID: 15572774
  • Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 2004; 60:2126 - 32; http://dx.doi.org/10.1107/S0907444904019158; PMID: 15572765
  • Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta Crystallogr D Biol Crystallogr 2010; 66:486 - 501; http://dx.doi.org/10.1107/S0907444910007493; PMID: 20383002
  • Vonrhein C, Flensburg C, Keller P, Sharff A, Smart O, Paciorek W, et al. Data processing and analysis with the autoPROC toolbox. Acta Crystallogr D Biol Crystallogr 2011; 67:293 - 302; http://dx.doi.org/10.1107/S0907444911007773; PMID: 21460447
  • Schrodinger LLC. . (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.